glp-1 news november 25 2025 FDA issued warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 Trends

Description

Given that the Mounjaro rollout plans for primary care physicians to be prescribers, there is a huge awareness challenge to be overcome, and very rapidly

(lf you use the patchovernight,remave it the next moming.) Safety Warning Please keep out of reach of children

This update elevates obesity within the global noncommunicable disease agenda and sets a clear mandate for action

Women over 50 in Palm Springs using Ozempic, Wegovy, or Mounjaro face increased risks of muscle loss and declining bone density after menopause

In this Review, the authors discuss the potential effects of GLP-1 receptor agonists on the incidence, disease activity and progression of various forms of arthritis, as well as practical considerations for their use in this context.